Here’s another look at HPPD, Hallucinogenic persistent perception disorder.
There are two types of HPPD: type 1 is characterised by brief "flashbacks", and type 2 sufferers experience chronic symptoms that can last months or a lifetime.
Read morePSYCHOTHERAPY FOR ADOLESCENTS, CHildren AND ADULTS
Here’s another look at HPPD, Hallucinogenic persistent perception disorder.
There are two types of HPPD: type 1 is characterised by brief "flashbacks", and type 2 sufferers experience chronic symptoms that can last months or a lifetime.
Read moreThis article looks at whether psychedelics are safe enough for recreational use.
Read moreExplore the extended difficulties following psychedelic use uncovered in a recent study.
Learn about long-term distress and coping strategies.
Read moreNew research has found that stressful or unsafe environments, negative expectations and a lack of social support during and after the psychedelic experience were all associated with negative outcomes when taking psychedelics.
Read morehow the nature of capitalism and returning profits to shareholders affects the concept of set and setting; how easy it is to prescribe ketamine and the puppy mill clinics popping up everywhere; how innovators are racing to the bottom to get ahead; the designer drug epidemic likely leading us to a Prozac Nation 2.0; digital narcissism, Instagram “Shamans,” and the dangers of cults; chemists trying to take the experience out of the drug; the overuse of psychedelics creating super egos; and much more.
Read moreThe most common forms of extended difficulty were feelings of anxiety and fear, existential struggle, social disconnection, depersonalization and derealization.
For approximately one-third of the participants, problems persisted for over a year, and for a sixth, they endured for more than three years.
It was found that a shorter duration of difficulties was predicted by knowledge of dose, drug type and lower levels of difficulty reported during the psychoactive experience, while a narrower range of difficulties was predicted by taking the drug in a guided setting.
Read moreThe harms of psychedelics need to be put Into context.
As psychedelic therapy trials get bigger and the drugs become more accessible, researchers need to start talking about their potential adverse effects.
Read more5-MeO-DMT is less commonly known compared to psilocybin and LSD.
But recently it has been gaining more attention as a therapeutic agent. 5-MeO-DMT creates one of the most powerful psychedelic experiences of any substance known.
Can it be used safely and what are the risks?
Read moreHere’s a great article on the potential benefits and high risks of 5-MeO-DMT from the Bufo toad… Along with the carelessness and unethical behavior of fake guru Octavio Rettig.
Read moreThis article is a huge warning of the risks of working with an inexperienced guide. Yikes!
Read more